The UBC spin-off companies are addressing key health challenges including precision cancer treatment, emergency healthcare and female sexual health.
Five spin-off companies founded by UBC Faculty of Medicine researchers have joined the latest HATCH Venture Builder cohort to help bring innovative health solutions from the lab into the clinic.
UBC’s HATCH program helps to propel early-stage venture growth, working with entrepreneurs to further develop their companies through mentorship, training, access to funding opportunities and over 10,000 square feet of office and makerspace. The new faculty of medicine-affiliated ventures to join HATCH in 2026 are developing solutions to key health challenges including precision cancer treatment, emergency healthcare and female sexual health. They are among 10 spin-off companies participating in the 2026 Winter cohort.
HATCH, a collaboration between Innovation UBC and the Institute for Computing Information and Cognitive Systems, supports the thriving community of interdisciplinary UBC innovators who are building ventures driving social, environmental and economic impact.
UBC Medicine-affiliated ventures
- eSense Health
eSense has developed the first clinically-validated self-directed digital platform for female sexual dysfunction based on gold standard psychological treatments.
Team: Dr. Lori Brotto, Dr. Kyle Stephenson, Elayne Wandler
Affiliation: Faculty of Medicine, Department of Obstetrics & Gynaecology
- phaseLab dynamics
phaseLab dynamics will transform Magnetic Resonance Imaging by controlling signal generation at its source, enabling faster, artifact-free, and highly reproducible scans.
Team: Christina Graf, Alexander Rauscher, Alexander Jaffray, Armin Rund, Cam Melvin
Affiliations: Faculty of Medicine, Department of Pediatrics; Faculty of Science, Department of Physics & Astronomy
- Promirin Therapeutics
At Promirin Therapeutics we are “flipping the switch on cancer” shutting down tumours at their source with precision gene control.
Team: Dr. Shane Duggan, Dr. Corina Stewart, Dr. Dermot Kelleher
Affiliation: Faculty of Medicine
- Resolve Nanotherapeutics
Developing novel universally active therapeutics for severe acute bacterial infections including pneumonia.
Team: Jim Russell, Cedric Brimacombe, Pieter Cullis, Ehsan Ansari Dezfouli
Affiliation: Faculty of Medicine, Division of Critical Care Medicine, Department of Biochemistry & Molecular Biology
- VitaPulse Technologies
VitaPulse is a digital health company that delivers clinically validated algorithms and alerting infrastructure to detect and predict life-threatening medical events, enabling faster recognition and response in the community.
Team: Saud Lingawi, Jacob Hutton
Affiliation: Faculty of Medicine